TrialClinical and translational science2022

A randomized, controlled, feasibility study of RD-X19 in subjects with mild-to-moderate COVID-19 in the outpatient setting.

Nathan Stasko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.